ABSTRACT We performed Illumina whole-genome sequencing on a carbapenemresistant Pseudomonas aeruginosa strain isolated from a cystic fibrosis patient with chronic airway colonization. The draft genome comprises 6,770,411 bp, including the carbapenemase bla NDM-1 and the extended-spectrum beta-lactamase bla PME-1 . This isolate harbors 3 prophages, 14 antibiotic resistance genes, and 257 virulence genes.
sequences (CDSs). The strain had a 66% GC content, 65 tRNA genes, 3 rRNA genes, and the 16S, 23S, and 5S loci (8) .
The genome of strain PA-81 contained 614 unique genes that were absent from the genome of the PAO1 reference strain (NCBI Reference Sequence number NC_002516). The strain belongs to sequence type 357 (ST357) (https://cge.cbs.dtu.dk/services/ MLST/) and serotype O11 (https://cge.cbs.dtu.dk/services/PAst/). Antibiotic resistance gene (ARG) annotation using the ResFinder and Comprehensive Antibiotic Resistance Database (CARD) servers (9, 10) revealed a number of ARGs against multiple classes of antibiotics, including beta-lactams (bla OXA-10 , bla OXA-50 , bla PAO , bla Amp-C , bla NDM-1 , and bla PME-1 ), aminoglycosides [aph(3=)-IIb, aph(3=)-VIa, ant(2Љ)-Ia, and aadA1], fosfomycin (fosA), trimethoprim (dfrB2), amphenicols (catB7), and sulfonamides (sul1). The presence of bla NDM-1 provides a likely mechanism of carbapenem resistance (11, 12) . Further analysis using PlasmidFinder v1.3 did not reveal any known plasmid replicons (13) . Three prophage regions of 21 kb, 12.6 kb, and 9.6 kb with identity scores of 90%, 85%, and 10%, respectively, were identified using PHAge Search Tool-Enhanced Release (PHASTER) (14) . Default settings were used for all the employed tools and software.
To the best of our knowledge, this is the first draft genome sequence of a bla NDM-1 -and bla PME-1 -harboring P. aeruginosa strain from Pakistan. A more detailed analysis of this genome will be reported in a future publication.
Data availability. This whole-genome shotgun project has been deposited at DDBJ/ ENA/GenBank under the accession number QXJN00000000 (version QXJN01000000) and SRA accession number SRR8510690. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.
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